IDP Pharma raises 1,5M€ its first operative year, supported by 1,2M€ of public funding.


IDP Pharma has closed a 1,5M€ seed investment round. The private funding adds to the 1,2M€ funds granted by several public institutions (MINECO, ENISA, CDTI-NEOTEC and ACCIÓ) in collaboration with Leitat, University of Salamanca (FICUS) and BCN Peptides. The company will allocate the capital to advance the preclinical development of its first product for cancer treatment and to continue developing its technology: IDP-Platform.